Literature DB >> 8625745

Inhibition of myofibroblastic transformation of cultured rat hepatic stellate cells by methylxanthines and dibutyryl cAMP.

N Kawada1, T Kuroki, K Kobayashi, M Inoue, K Kaneda.   

Abstract

Stellate cells isolated from rat liver and cultured on uncoated plastic plates in serum-containing medium started proliferating and transforming to myofibroblastic cells. However, stellate cells did not proliferate when cultured in the presence of 3-isobutyl-1-methylxanthine or dibutyryl cAMP (dBcAMP). These substances significantly reduced [3h] thymidine incorporation of the proliferating cells. Morphologically, stellate cells cultured in the presence of 3-isobutyl-1-methylxanthine or dibutyryl cAMP kept well-developed processes and lipid droplets while untreated cells exhibited myofibroblastic characteristics. Western blot analysis and immunocytochemical studies revealed that 3-isobutyl-1-methylxanthine and dBcAMP suppressed the expression of alpha-smooth muscle actin in stellate cells. 3-isobutyl-1-methylxanthine increased the cellular levels of cAMP from a basal value of 0.7 +/- 0.1 to 8.5 +/- 1.7 pmol/well in stellate cells. Thus, 3-isobutyl-1-methylxanthine and dBcAMP inhibit the myofibroblastic transformation of stellate cells in vitro in some cAMP-related mechanism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8625745     DOI: 10.1007/bf02091547

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  24 in total

1.  Selective inhibition of cyclic nucleotide phosphodiesterases by analogues of 1-methyl-3-isobutylxanthine.

Authors:  G L Kramer; J E Garst; S S Mitchel; J N Wells
Journal:  Biochemistry       Date:  1977-07-26       Impact factor: 3.162

Review 2.  Cellular sources of noncollagenous matrix proteins: role of fat-storing cells in fibrogenesis.

Authors:  A M Gressner; M G Bachem
Journal:  Semin Liver Dis       Date:  1990-02       Impact factor: 6.115

3.  Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors.

Authors:  S L Friedman; M J Arthur
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

Review 4.  A new generation of phosphodiesterase inhibitors: multiple molecular forms of phosphodiesterase and the potential for drug selectivity.

Authors:  R E Weishaar; M H Cain; J A Bristol
Journal:  J Med Chem       Date:  1985-05       Impact factor: 7.446

5.  Retinoic acid modulates rat Ito cell proliferation, collagen, and transforming growth factor beta production.

Authors:  B H Davis; R T Kramer; N O Davidson
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

6.  Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells.

Authors:  M Pinzani; L Gesualdo; G M Sabbah; H E Abboud
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

7.  Intralobular heterogeneity of perisinusoidal stellate cells in porcine liver.

Authors:  K Wake; T Sato
Journal:  Cell Tissue Res       Date:  1993-08       Impact factor: 5.249

8.  Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3',5'-monophosphate.

Authors:  J Wu; P Dent; T Jelinek; A Wolfman; M J Weber; T W Sturgill
Journal:  Science       Date:  1993-11-12       Impact factor: 47.728

9.  Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor beta: implication for a pathogenetic role in alcoholic liver fibrogenesis.

Authors:  M Matsuoka; H Tsukamoto
Journal:  Hepatology       Date:  1990-04       Impact factor: 17.425

10.  The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-alpha production by human mononuclear cells.

Authors:  J Semmler; H Wachtel; S Endres
Journal:  Int J Immunopharmacol       Date:  1993-04
View more
  5 in total

Review 1.  Regulating cellular cyclic adenosine monophosphate: "Sources," "sinks," and now, "tunable valves".

Authors:  Michael Getz; Padmini Rangamani; Pradipta Ghosh
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2020-04-23

2.  A novel small compound that promotes nuclear translocation of YB-1 ameliorates experimental hepatic fibrosis in mice.

Authors:  Kiyoshi Higashi; Yoshitaka Tomigahara; Hiroaki Shiraki; Kaori Miyata; Toshiyuki Mikami; Toru Kimura; Tadashi Moro; Yutaka Inagaki; Hideo Kaneko
Journal:  J Biol Chem       Date:  2010-11-28       Impact factor: 5.157

3.  Prostaglandin E2 inhibits platelet-derived growth factor-stimulated cell proliferation through a prostaglandin E receptor EP2 subtype in rat hepatic stellate cells.

Authors:  Shigeki Koide; Yoshimasa Kobayashi; Yutaka Oki; Hirotoshi Nakamura
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

Review 4.  Role of cAMP and phosphodiesterase signaling in liver health and disease.

Authors:  Banrida Wahlang; Craig McClain; Shirish Barve; Leila Gobejishvili
Journal:  Cell Signal       Date:  2018-06-11       Impact factor: 4.315

Review 5.  cAMP Signaling in Pathobiology of Alcohol Associated Liver Disease.

Authors:  Mohamed Elnagdy; Shirish Barve; Craig McClain; Leila Gobejishvili
Journal:  Biomolecules       Date:  2020-10-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.